Bosnalijek D.D: Clinical Trials

2 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	3	Completed 2, Terminated 1
Phase 2	1	Completed 1

Follow Bosnalijek D.D: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder Quetiapine (drug), quetiapine + aripiprazole, quetiapine + haloperidol - Schizophrenia, Bipolar Affective Disorder		Recruiting	Bosnalijek D.D	500	2025-10-30	2026-10-15
Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation Apixaban - Nonvalvular Atrial Fibrillation		Recruiting	Bosnalijek D.D	800	2025-10-09	2026-03-11
Monitoring the Effectiveness and Safety of Antihypertensive Therapy With a Fixed-Dose Combination of Perindopril and Amlodipine in Patients With Uncontrolled Essential Hypertension fixed combination of perindopril + amlodipine - Essential Hypertension		Active not recruiting	Bosnalijek D.D	600	2025-01-16	2026-10-15
Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection metenkefalin + tridecactide, The standard of care - COVID-19 Infection	Phase 2 / Phase 3	Completed	Bosnalijek D.D	120	2020-05-01	2020-12-24
A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS EK-12, INF beta-1a - Multiple Sclerosis, Relapsing-Remitting	Phase 3	Terminated	Bosnalijek D.D	301	2019-03-26	2024-08-13
Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat Lysobact Complete Sprey, Tantum Verde® Spray, Pharyngal® Oromucosal Spray - Sore Throat	Phase 3	Completed	Bosnalijek D.D	346	2016-10-01	2021-03-16

Conditions studied

Bipolar Disorder (1)  ·  COVID-19 (1)  ·  Essential Hypertension (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Pharyngitis (1)  ·  Schizophrenia (1)

Interventions

Amlodipine (1)  ·  Aripiprazole (1)  ·  Enkephalin, Methionine (1)  ·  Haloperidol (1)  ·  Pharmaceutical Preparations (1)  ·  Quetiapine Fumarate (1)  ·  apixaban (1)

Countries

Bosnia and Herzegovina (5)  ·  Turkey (Türkiye) (1)

Top investigators

Husnu Efendi, Prof (1)